Novo Nordisk provides funding for diabetes initiatives

Drug maker provides funding for organizations in Seattle, Rochester, Minn., and Portland, Ore.

NEW YORK — Diabetes organizations in several cities are getting a boost in funding from a Danish drug maker that specializes in developing treatments for the disease.

Novo Nordisk said it would provide funding to groups in Seattle; Portland, Ore.; and Rochester, Minn., as part of the Novo Nordisk Community Care initiative. The initiative provides funding to nonprofits that support educational programs for people with Type 2 diabetes.

Groups in Seattle receiving funding include the Center for MultiCultural Health, the EvergreenHealth Foundation, Senior Services and the University of Washington Foundation. In Portland, recipients include the African American Health Coalition, the Harold Schnitzer Diabetes Health Center at Oregon Health and Science University, Legacy Health and the Wallace Medical Concern. The Mayo Clinic and Migrant Health Service are the groups in Rochester receiving funding.


Login or Register to post a comment.